Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Recognized diabetes clinic in Germany evaluates VibroSense Meter® II

The diabetes clinic at the university hospital Klinikum Stuttgart evaluates the VibroSenseMeter®II, starting on October 11, 2022. A Research collaboration between the clinic and VibroSense Dynamics focusing on nerve damage in the feet caused by diabetes is also  discussed.The diabetes clinic at Klinikum Stuttgart is a highly recognized clinic that treats people with diabetes type 1 or 2. The goal is to use the VibroSense Meter II and the application "Diabetic Foot Screening" as a standard examination of people with diabetes on the clinic. The clinic also works with research to study

Presentation of phase l/lla clinical data of FG001 in aggressive brain cancer at the European Congress of Neurosurgery 2022

Copenhagen, Denmark, 6 October 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to inform that the Principal Investigator, Chief Surgeon Jane Skjøth-Rasmussen will be presenting the outstanding clinical data from the completed phase I/IIa trial with FG001 in patients with aggressive brain cancer undergoing surgery at the European Congress of Neurosurgery on 19 October 2022 in Belgrade, Serbia.The excellent phase l/lla clinical data of FG001 in aggressive brain cancer will be presented by Principal Investigator and Chief Surgeon Jane Skjøth-Rasmussen at the European Congress of

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 202 - 6 OCTOBER 2022  In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcement no. 158/22. A/S Motortramp participates in NORDEN’s share buy-back program by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in NORDEN.     Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Thomas France, Investor

Drug diversion – a growing problem in healthcare

As a result of the opioid crisis, the embezzlement of narcotic drugs, known as drug diversion, is a growing problem in healthcare. The demand for solutions that prevent prescription drugs from falling into the wrong hands is steadily increasing in line with higher demands for drug safety. BioStock reports on the latest findings from the US with comments from the organisation IHFDA's President Marsha Stanton. Additionally, attention is drawn to a technical solution against drug diversion from the Swedish company Pharmacolog.Read the full article at biostock.se:https://www.biostock.se/en/

Frog Events at 10: A celebration of innovation and success

Frog Events are delighted to be celebrating its 10th anniversary.[Corporate Events Venue [Franco de laGeneral Manager and Event CroixVaubois headshotProducer] option one] \Bristol, 6th October 2022\ \For immediate release:\ Frog Events is delighted to be celebrating its 10th anniversary. Over the past 10 years, Frog Events under the guidance of Franco de la Croix-Vaubois, has become one of the UK’s leading virtual event organisers, bringing people together through in-person, virtual, and hybrid events. “We are so proud of what we have achieved over

Zalaris recognised by Gartner® in 2022 Market Guide for Multi-country Payroll Solutions

Zalaris, the provider of payroll and HR solutions that simplify work life and support creating sustainable businesses, today announced that it has been included in the 2022 Gartner Market Guide for Multi-country PayrollGartner, a company that delivers actionable, objective insight to executives and their teams, recognised Zalaris in its recently launched Market Guide for Multi-country Payroll Solutions.  Gartner added that “Hybrid working has empowered employees to continue operating from payroll jurisdictions that are different from the organization’s registered offices. HR is also

Nexam Chemical takes first major order from South Korea

- Another success for reactive plastic recycling Nasdaq First North-listed Nexam Chemical – which invents, develops, produces and sells additives to the plastics industry worldwide – takes the largest order to date in the South Korean market. The order applies to the Reactive Recycling area for recycled PET to a value of approximately SEK 1 million.Nexam Chemical has previously announced that the company has a new agent in Seoul, which has successfully started to develop the market with a focus on reactive recycling. Reactive Recycling, is a product series from Nexam Chemical that can

Clas Ohlson's second store in Vaasa is now open

This morning, Clas Ohlson opened a new store in Vaasa, Finland. The store opening is part of Clas Ohlson's strategy to grow in the Finnish market.The new store is located in Klemettilään just outside central Vaasa. With the opening, Clas Ohlson will have two stores in Vaasa. “We opened our first store in Vaasa in 2004 and over the years we have gained many customers who appreciate our wide range for home fixing.  With the new store in Klemettilään, we become even more accessible to our customers," says Carita Degerman, Country Operations Manager. The store opening is also part of Clas

AstraZeneca builds on the fight against rare diseases

Swedish-British pharmaceutical giant AstraZeneca showed with its multibillion USD acquisition of Alexion that it is serious about its push in rare diseases. Now they are following up with another acquisition in the form of the small American biotech company LogicBio. The deal, announced  on Monday, is set to close at $2.07 per share – a premium of a whopping 660 per cent to Friday’s close on the U.S. Nasdaq Stock Exchange.Read the full article at biostock.se: https://www.biostock.se/en/2022/10/astrazeneca-builds-on-the-fight-against-rare-diseases/ This is a press release from BioStock

Gold certified offices for Wallenstam

Wallenstam’s headquarters in Gothenburg has been nominated as a finalist in the Sweden Green Building Awards 2022 competition. Both the company’s headquarters and the regional office in Stockholm are also certified in the gold category according to the Environmental Building In-Use (Miljöbyggnad iDrift) rating system developed by the Swedish Green Building Council (SGBC). This certification is based on five areas, internal environment, health, climate impact, resources and condition, which in turn includes 14 indicators. Through effective collaboration and a clear focus on goals, the

Instalco wins contract to participate in the expansion of Falu Hospital

The Instalco companies, Henningsons El, Dalab and Intec have been jointly engaged for work associated with the renovation and expansion of the intensive care unit at Falu Hospital. The work includes design and installation, with a total order value of approximately SEK 140 million.It is a partnering project together with ByggDialog, Regionfastigheter Dalarna and other partners. Instalco is responsible for the electrical installations (Henningsons), ventilation (Dalab) and design (Intec). Environmental responsibility is a key element of the project, which will be achieved through energy-

Invitation to the presentation of Axfood’s third quarter 2022

Axfood invites investors, analysts and the press to a presentation of the interim report for the third quarter 2022 at 9:30 am CET on 20 October. The report will be published at 7:00 am CET the same day.Axfood’s President and CEO Klas Balkow will present the report together with CFO Anders Lexmon. The presentation will be held in English. Time: Thursday, 20 October at 9:30 am CET To participate, please dial in:Sweden: +46 8 505 583 56The UK+44 333 300 9260The US: +1 646 7224 957 The presentation can also be followed live via webcast at axfood.com 

NanoCap reports preliminary turnover for subsidiaries September 2022

Stockholm 2022-10-06 NanoCap Group has received preliminary sales figures from the non-listed subsidiaries for September 2022. The sales provisionally amounted to approx. SEK 6.5 million SEK (approx. SEK 4.5 million in 2021).   // This press release is a translation from the main language, which is Swedish. For more information, contact the company at: Telephone: +46 (0)8-410 59 140 ir(at)nanocapgroup.com www.nanocapgroup.com   NanoCap Group AB (publ) NanoCap invests in growth companies, primarily unlisted, as well as develops and launches its own in-house

Oriola Corporation will publish its Interim report 1 January-30 September on Thursday, 27 October 2022 approximately at 8.30 a.m

Oriola Corporation Investor news 6 October 2022 at 10.00 a.m. Oriola Corporation will publish its Interim report 1 January-30 September on Thursday, 27 October 2022 approximately at 8.30 a.m. Oriola Corporation will organise a live-webcast meeting for investors, analysts and the press on Thursday 27 October 2022 at 10.00 a.m. The event can be followed as a live-webcast accessible through this link: https://oriola.videosync.fi/2022-q3-interimreport. The event will be arranged only as a webcast. The language of the event will be English. The meeting will be recorded and there is a

Slättö makes senior hires – appoints new Country Head, Finland and Sector Head, Hotels

Slättö recruits Ilkka Salminen as Country Head, Finland and Erik Möller as Sector Head, Hotels. The recruitments will support Slättö’s growth strategy in the Nordic region and further strengthen the firm’s well-reputed team.Slättö has recruited Ilkka Salminen as Country Head, Finland and Erik Möller as Sector Head, Hotels in the investment team. Ilkka brings substantial real estate investment experience and will play a key role in driving Slättö’s growth in Finland. Ilkka joins Slättö from a role as investment team lead at NREP, where he most recently headed residential transactions in

Strategic Plan for Electric Vehicle Inzile, EVI

Within its Strategic Plan, Inzile has decided to focus all its efforts on the Electric Vehicle Inzile (EVI), while recognizing the excellent work of the Inzile R&D department in Tranås, Sweden with the collaboration of leading technology partners, such as the Swedish T-Engineering, part of Dongfeng Motor Corporation, and other international companies. Now, Inzile, through its subsidiary EVI Mobility (former QEV Tech Holding, 80% owned by Inzile) will complete the EVI platform project with the collaboration of QEV Technologies (Barcelona) for the future homologation of the vehicle for

Nokian Tyres: Disclosure under chapter 9, section 10 of the securities market act

Nokian Tyres plc Stock Exchange Release October 6, 2022 at 9:55 a.m. Nokian Tyres has received an announcement from BlackRock, Inc. on October 5, 2022, in accordance with the Finnish Securities Market Act Chapter 9, Section 5. According to the announcement, the indirect holding in Nokian Tyres shares owned by BlackRock, Inc. and its funds fell below the level of 5% of the share capital of Nokian Tyres plc, as a result of share transactions concluded on October 4, 2022. Total positions of BlackRock, Inc. and its funds subject to the notification: +----------------+----------+--------

Scandinavian ChemoTech expands its management team with further clinical competency

We are very pleased to announce the appointment of Dr Mufti as our Medical Director. Dr Mufti has been playing a crucial part as a consulting Medical Advisor where he, amongst other things, has been representing ChemoTech and our technology in the preparations to start the TSE trial at AIIMS Jodhpur.Dr Mufti is a board-certified onco-pathologist and translational oncology professional with extensive experience in the design and execution of early-phase clinical trials and non-clinical regulatory studies. He did his medical graduated from the prestigious Government Medical College, Srinagar

Starbreeze Returns to Publishing with Upcoming - THE TRIBE MUST SURVIVE

Lovecraftian tribe-building strategy game by Walking Tree Games will launch in 2023 Stockholm – Thursday, October 6, 2022 – Starbreeze has signed an agreement with development studio Walking Tree Games to publish their upcoming game THE TRIBE MUST SURVIVE , marking a return to the world of third-party publishing by Starbreeze, the team behind the commercial hit PAYDAY  series. Today’s announcement also includes a newly dedicated publishing arm of Starbreeze, who will apply their deep expertise in

BioStock at NLSDays: Interviews with 10 interesting companies

On September 28-29, SwedenBIO arranged Nordic Life Science Days in Malmö, the largest Nordic partnering- and networking conference in the life science industry. Over 1000 companies and 100 investors attended the event, and before the event even started, approximately 3000 partnering meetings were scheduled. BioStock was there and got the chance to talk to a number of interesting companies within the field.See the interviews at biostock.se: https://www.biostock.se/en/2022/10/nlsdays-interviews-with-10-interesting-companies/ This is a press release from BioStock - Connecting Innovation &

Rejlers wins assignment for GlobalConnect

Rejlers has won the assignment to participate in the migration of agreements, networks and customers for the fiber network supplier GlobalConnect. The assignment is part of GlobalConnect's acquisition of the communications operator Open Universe and Telenor Sweden’s SDU fiber assets from Telenor Sweden.“We are pleased to help GlobalConnect with this acquisition, which is one of the largest in the industry. We have both the knowledge and capacity to take on the migration of data through smart digital solutions, which is an important part of the integration of the companies," says Niklas

Invitation to press and analyst conference in Stockholm

The Volvo Group report for the third quarter 2022 will be published on October 20, 2022 at 7.20 a.m. CEST.A press conference will be held at Tändstickspalatset, Västra Trädgårdsgatan 15 in Stockholm at 9.00 a.m. CEST. The Volvo Group will be represented by President and CEO Martin Lundstedt and Executive Vice President Group Finance and CFO Tina Hultkvist. Press and Analysts Conference 9.00 a.m. CEST. Access the webcast here.  To participate in the press conference via conference call, participants may pre-register and

Extensive new preclinical study significantly increases the Translatability of Asarina Pharma’s findings on key stress mechanism implicated in Tourette Syndrome and OCD

(Stockholm, 6 October 2022.) A new study in the journal Neurobiology of Stress reconfirms the central role the neurosteroid Allopregnanolone (ALLO) plays in stress-related conditions such as Tourette syndrome and OCD, and the efficacy of its endogenous modulator isoallopregnanolone in modulating its negative effects. This is the most extensive of four preclinical studies confirming these findings, significantly increasing the Translatability of data. Asarina Pharma is testing isoallopregnanolone (under the name Sepranolone) for Tourette syndrome in a Phase IIa study, with the last patient

HC Andersen Capital SaaS Event 06.10: Meet the top management in Faundit, Penneo & Efecte.

SAAS – UNDERSTAND THE LIFE CYCLE/INVESTMENT PHASEToday we will host a virtual Software-as-a-Service (SaaS) event focusing on the different investment phases and the life cycle of SaaS companies.In the event you can meet Faundit, Penneo & Efecte. To shed light on this topic, which is a part of our new SaaS investor series, we have invited the management from a bootstrapped company (private company, Faundit), heavy growth investments company (listed company, Penneo), and balanced growth with positive net income (listed company, Efecte)Why is this relevant? Investors should know that

There are no items matching the current filter
There are no more items matching the current filter
Back to top